Literature DB >> 1770775

Liver transplantation in two children with tyrosinaemia type I: biochemical aspects.

E Riudor1, A Ribes, J Lloret, J Friden, E Holme, C Jakobs, V Martinez Ibanez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1770775     DOI： 10.1007/bf01811682

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  7 in total

Review 1.  Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma.

Authors:  T E Starzl; B J Zitelli; B W Shaw; S Iwatsuki; J C Gartner; R D Gordon; J J Malatuck; I J Fox; A H Urbach; D H Van Thiel
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

2.  Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia.

Authors:  E Holme; B Lindblad; S Lindstedt
Journal:  Lancet       Date:  1985-03-02       Impact factor: 79.321

3.  Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acid.

Authors:  D P Tschudy; R A Hess; B C Frykholm
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

4.  Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma.

Authors:  S L Tsai; G T Huang; P M Yang; J C Sheu; J L Sung; D S Chen
Journal:  Hepatology       Date:  1990-03       Impact factor: 17.425

5.  The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.

Authors:  E A Kvittingen; E Brodtkorb
Journal:  Scand J Clin Lab Invest Suppl       Date:  1986

6.  Determination of urinary succinylacetone by capillary gas chromatography.

Authors:  M Tuchman; C B Whitley; M L Ramnaraine; L D Bowers; K D Fregien; W Krivit
Journal:  J Chromatogr Sci       Date:  1984-05       Impact factor: 1.618

7.  Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and neonatal diagnosis of hereditary tyrosinemia type I.

Authors:  C Jakobs; L Dorland; B Wikkerink; R M Kok; A P de Jong; S K Wadman
Journal:  Clin Chim Acta       Date:  1988-02-15       Impact factor: 3.786
  7 in total
  1 in total

1.  Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Authors:  M Grompe; K Overturf; M al-Dhalimy; M Finegold
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.